Company Filing History:

19 out of 677

Eisai Company, Limited

patents

1 out of 527

Eisai R&d Management Co., Ltd.

patents

Years Active: 1989-2008

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7378425 - (1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds (2008-05-27),

2. 6677330 - Fluorides of 4-substituted piperidine derivatives (2004-01-13),

3. 6281214 - Biphenyl derivatives (2001-08-28),

4. 6277866 - 1-benzyl-4[(5,6-dimethoxy-2-fluoro-1-indanon)-2-yl]methylpiperidine (2001-08-21),

5. 5919778 - Cyclic amide derivatives (1999-07-06),

6. 5849912 - Biphenyl derivatives (1998-12-15),

7. 5654308 - Bicyclic amide derivatives, compositions and methods of treatment (1997-08-05),

8. 5654306 - Piperidine derivative and pharmaceutical composition (1997-08-05),

9. 5620976 - Benzoxazine derivatives (1997-04-15),

10. 5521182 - 1,2,3,4 tetrahydropteridinone cyclic amide derivatives (1996-05-28),

11. 5504088 - 2H-3,4-tetrahydroquinazoline-2-one and (1996-04-02),

12. 5424318 - Piperidine derivative and pharmaceutical composition (1995-06-13),

13. 5306720 - Piperidine derivative and pharmaceutical composition (1994-04-26),

14. 5292735 - Cyclic amide derivatives (1994-03-08),

15. 5118684 - Piperdine derivative and pharmaceutical composition (1992-06-02),

Title: Yoshiharu Yamanishi: Innovator in Pharmaceutical Compounds

Introduction

Yoshiharu Yamanishi, located in Ibaraki, Japan, is a prolific inventor known for his significant contributions to the field of pharmaceutical compounds. With an impressive portfolio of 20 patents, he has played a critical role in developing innovative solutions that enhance medical therapies.

Latest Patents

Among his latest patents is the invention of (1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds. This invention presents an excellent sigma receptor binding agent and/or acetylcholinesterase inhibitor, showcasing the potential of these compounds in therapeutic applications. The specific compound structure is represented in his patent, along with pharmacologically acceptable salts or hydrates. Additionally, Yamanishi has developed fluorides of 4-substituted piperidine derivatives, which contribute to the advancement of medicinal chemistry.

Career Highlights

Yamanishi has built a formidable career, primarily working with Eisai Company, Limited and Eisai R&D Management Co., Ltd. His innovative spirit and commitment to research have propelled him to the forefront of pharmaceutical advancements. His 20 patents reflect his dedication to creating effective solutions in the healthcare sector.

Collaborations

Throughout his career, Yamanishi has collaborated with talented individuals in the industry, including Hachiro Sugimoto and Norio Karibe. These partnerships have fostered a creative environment that enhances the development of groundbreaking inventions, contributing to the overall success of the projects he has been involved in.

Conclusion

Yoshiharu Yamanishi's work exemplifies the intersection of innovation and application in the field of pharmaceuticals. His latest patents and collaborations continue to influence medical research, offering new potential treatments for a variety of conditions. As he progresses in his career, the impact of his inventions is likely to be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.